Iris Clothings Limited
Iris Clothings Limited (IRISDOREME.NS) Stock Competitors & Peer Comparison
See (IRISDOREME.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IRISDOREME.NS | ₹36.59 | +2.72% | 6.1B | 46.74 | ₹0.76 | N/A |
| PAGEIND.BO | ₹38,717.65 | +5.22% | 418.5B | 55.72 | ₹673.36 | +1.60% |
| PAGEIND.NS | ₹38,700.00 | +5.11% | 418.3B | 55.97 | ₹670.12 | +1.60% |
| KPRMILL.NS | ₹956.65 | +3.60% | 311.7B | 35.92 | ₹25.39 | +0.55% |
| KPRMILL.BO | ₹957.70 | +3.65% | 311.2B | 35.95 | ₹25.32 | +0.55% |
| VTL.NS | ₹613.70 | +1.11% | 172.3B | 22.77 | ₹26.16 | +0.84% |
| VTL.BO | ₹613.75 | +1.28% | 172.2B | 22.74 | ₹26.18 | +0.84% |
| ALOKTEXT.BO | ₹37.04 | +3.81% | 161.2B | -0.72 | -₹51.22 | N/A |
| WELSPUNIND.NS | ₹159.00 | +0.03% | 153B | 29.39 | ₹5.41 | N/A |
| WELSPUNLIV.NS | ₹140.39 | -0.45% | 132.5B | 56.60 | ₹2.45 | +1.23% |
Stock Comparison
IRISDOREME.NS vs PAGEIND.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, PAGEIND.BO has a market cap of 418.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while PAGEIND.BO trades at ₹38,717.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas PAGEIND.BO's P/E ratio is 55.72. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to PAGEIND.BO's ROE of +0.52%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to PAGEIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check PAGEIND.BO's competition here
IRISDOREME.NS vs PAGEIND.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, PAGEIND.NS has a market cap of 418.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while PAGEIND.NS trades at ₹38,700.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas PAGEIND.NS's P/E ratio is 55.97. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to PAGEIND.NS's ROE of +0.52%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to PAGEIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check PAGEIND.NS's competition here
IRISDOREME.NS vs KPRMILL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, KPRMILL.NS has a market cap of 311.7B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while KPRMILL.NS trades at ₹956.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas KPRMILL.NS's P/E ratio is 35.92. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to KPRMILL.NS's ROE of +0.16%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to KPRMILL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check KPRMILL.NS's competition here
IRISDOREME.NS vs KPRMILL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, KPRMILL.BO has a market cap of 311.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while KPRMILL.BO trades at ₹957.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas KPRMILL.BO's P/E ratio is 35.95. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to KPRMILL.BO's ROE of +0.16%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to KPRMILL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check KPRMILL.BO's competition here
IRISDOREME.NS vs VTL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, VTL.NS has a market cap of 172.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while VTL.NS trades at ₹613.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas VTL.NS's P/E ratio is 22.77. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to VTL.NS's ROE of +0.07%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to VTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check VTL.NS's competition here
IRISDOREME.NS vs VTL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, VTL.BO has a market cap of 172.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while VTL.BO trades at ₹613.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas VTL.BO's P/E ratio is 22.74. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to VTL.BO's ROE of +0.07%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to VTL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check VTL.BO's competition here
IRISDOREME.NS vs ALOKTEXT.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ALOKTEXT.BO has a market cap of 161.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ALOKTEXT.BO trades at ₹37.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ALOKTEXT.BO's P/E ratio is -0.72. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ALOKTEXT.BO's ROE of +0.03%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to ALOKTEXT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ALOKTEXT.BO's competition here
IRISDOREME.NS vs WELSPUNIND.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, WELSPUNIND.NS has a market cap of 153B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while WELSPUNIND.NS trades at ₹159.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas WELSPUNIND.NS's P/E ratio is 29.39. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to WELSPUNIND.NS's ROE of +0.05%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to WELSPUNIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check WELSPUNIND.NS's competition here
IRISDOREME.NS vs WELSPUNLIV.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, WELSPUNLIV.NS has a market cap of 132.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while WELSPUNLIV.NS trades at ₹140.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas WELSPUNLIV.NS's P/E ratio is 56.60. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to WELSPUNLIV.NS's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to WELSPUNLIV.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check WELSPUNLIV.NS's competition here
IRISDOREME.NS vs WELSPUNLIV.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, WELSPUNLIV.BO has a market cap of 132.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while WELSPUNLIV.BO trades at ₹140.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas WELSPUNLIV.BO's P/E ratio is 56.57. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to WELSPUNLIV.BO's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to WELSPUNLIV.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check WELSPUNLIV.BO's competition here
IRISDOREME.NS vs ARVIND.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ARVIND.BO has a market cap of 123.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ARVIND.BO trades at ₹485.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ARVIND.BO's P/E ratio is 30.62. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ARVIND.BO's ROE of +0.11%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ARVIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ARVIND.BO's competition here
IRISDOREME.NS vs TRIDENT.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, TRIDENT.NS has a market cap of 123.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while TRIDENT.NS trades at ₹24.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas TRIDENT.NS's P/E ratio is 30.40. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to TRIDENT.NS's ROE of +0.09%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to TRIDENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check TRIDENT.NS's competition here
IRISDOREME.NS vs ARVIND.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ARVIND.NS has a market cap of 123.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ARVIND.NS trades at ₹485.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ARVIND.NS's P/E ratio is 30.63. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ARVIND.NS's ROE of +0.11%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ARVIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ARVIND.NS's competition here
IRISDOREME.NS vs TRIDENT.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, TRIDENT.BO has a market cap of 123.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while TRIDENT.BO trades at ₹24.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas TRIDENT.BO's P/E ratio is 30.38. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to TRIDENT.BO's ROE of +0.09%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to TRIDENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check TRIDENT.BO's competition here
IRISDOREME.NS vs SWANENERGY.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SWANENERGY.NS has a market cap of 103.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SWANENERGY.NS trades at ₹331.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SWANENERGY.NS's P/E ratio is 13.68. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SWANENERGY.NS's ROE of -0.00%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SWANENERGY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SWANENERGY.NS's competition here
IRISDOREME.NS vs SWANENERGY.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SWANENERGY.BO has a market cap of 97.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SWANENERGY.BO trades at ₹313.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SWANENERGY.BO's P/E ratio is 12.50. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SWANENERGY.BO's ROE of -0.00%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SWANENERGY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SWANENERGY.BO's competition here
IRISDOREME.NS vs ABFRL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ABFRL.BO has a market cap of 75.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ABFRL.BO trades at ₹62.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ABFRL.BO's P/E ratio is -8.88. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ABFRL.BO's ROE of -0.11%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ABFRL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ABFRL.BO's competition here
IRISDOREME.NS vs ABFRL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ABFRL.NS has a market cap of 75.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ABFRL.NS trades at ₹62.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ABFRL.NS's P/E ratio is -8.88. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ABFRL.NS's ROE of -0.11%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ABFRL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ABFRL.NS's competition here
IRISDOREME.NS vs PGIL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, PGIL.NS has a market cap of 73.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while PGIL.NS trades at ₹1,604.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas PGIL.NS's P/E ratio is 28.06. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to PGIL.NS's ROE of +0.23%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to PGIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check PGIL.NS's competition here
IRISDOREME.NS vs PGIL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, PGIL.BO has a market cap of 73.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while PGIL.BO trades at ₹1,602.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas PGIL.BO's P/E ratio is 27.98. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to PGIL.BO's ROE of +0.23%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to PGIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check PGIL.BO's competition here
IRISDOREME.NS vs ALOKINDS.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ALOKINDS.NS has a market cap of 65.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ALOKINDS.NS trades at ₹12.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ALOKINDS.NS's P/E ratio is -8.79. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ALOKINDS.NS's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ALOKINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ALOKINDS.NS's competition here
IRISDOREME.NS vs GARFIBRES.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GARFIBRES.NS has a market cap of 63.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GARFIBRES.NS trades at ₹642.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GARFIBRES.NS's P/E ratio is 30.11. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GARFIBRES.NS's ROE of +0.17%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GARFIBRES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GARFIBRES.NS's competition here
IRISDOREME.NS vs GARFIBRES.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GARFIBRES.BO has a market cap of 63.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GARFIBRES.BO trades at ₹641.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GARFIBRES.BO's P/E ratio is 30.01. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GARFIBRES.BO's ROE of +0.17%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GARFIBRES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GARFIBRES.BO's competition here
IRISDOREME.NS vs ICIL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ICIL.NS has a market cap of 59.1B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ICIL.NS trades at ₹306.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ICIL.NS's P/E ratio is 49.40. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ICIL.NS's ROE of +0.05%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ICIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ICIL.NS's competition here
IRISDOREME.NS vs ICIL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ICIL.BO has a market cap of 59B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ICIL.BO trades at ₹305.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ICIL.BO's P/E ratio is 35.59. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ICIL.BO's ROE of +0.05%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ICIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ICIL.BO's competition here
IRISDOREME.NS vs ARVINDFASN.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ARVINDFASN.NS has a market cap of 57.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ARVINDFASN.NS trades at ₹429.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ARVINDFASN.NS's P/E ratio is 46.48. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ARVINDFASN.NS's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ARVINDFASN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ARVINDFASN.NS's competition here
IRISDOREME.NS vs ARVINDFASN.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, ARVINDFASN.BO has a market cap of 57.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while ARVINDFASN.BO trades at ₹429.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas ARVINDFASN.BO's P/E ratio is 46.31. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to ARVINDFASN.BO's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to ARVINDFASN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check ARVINDFASN.BO's competition here
IRISDOREME.NS vs GOKEX.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GOKEX.NS has a market cap of 49.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GOKEX.NS trades at ₹691.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GOKEX.NS's P/E ratio is 43.09. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GOKEX.NS's ROE of +0.06%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GOKEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GOKEX.NS's competition here
IRISDOREME.NS vs GOKEX.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GOKEX.BO has a market cap of 49.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GOKEX.BO trades at ₹691.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GOKEX.BO's P/E ratio is 43.05. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GOKEX.BO's ROE of +0.06%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GOKEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GOKEX.BO's competition here
IRISDOREME.NS vs GBGLOBAL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GBGLOBAL.NS has a market cap of 46.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GBGLOBAL.NS trades at ₹930.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GBGLOBAL.NS's P/E ratio is -0.03. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GBGLOBAL.NS's ROE of +0.16%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to GBGLOBAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GBGLOBAL.NS's competition here
IRISDOREME.NS vs RAYMONDLSL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RAYMONDLSL.NS has a market cap of 45.7B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RAYMONDLSL.NS trades at ₹743.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RAYMONDLSL.NS's P/E ratio is 99.17. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RAYMONDLSL.NS's ROE of +0.00%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RAYMONDLSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RAYMONDLSL.NS's competition here
IRISDOREME.NS vs RAYMONDLSL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RAYMONDLSL.BO has a market cap of 45.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RAYMONDLSL.BO trades at ₹744.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RAYMONDLSL.BO's P/E ratio is 99.19. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RAYMONDLSL.BO's ROE of +0.00%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RAYMONDLSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RAYMONDLSL.BO's competition here
IRISDOREME.NS vs LUXIND.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, LUXIND.NS has a market cap of 40B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while LUXIND.NS trades at ₹1,384.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas LUXIND.NS's P/E ratio is 37.03. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to LUXIND.NS's ROE of +0.06%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to LUXIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check LUXIND.NS's competition here
IRISDOREME.NS vs LUXIND.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, LUXIND.BO has a market cap of 39.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while LUXIND.BO trades at ₹1,383.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas LUXIND.BO's P/E ratio is 36.61. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to LUXIND.BO's ROE of +0.06%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to LUXIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check LUXIND.BO's competition here
IRISDOREME.NS vs TCNSBRANDS.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, TCNSBRANDS.BO has a market cap of 37B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while TCNSBRANDS.BO trades at ₹584.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas TCNSBRANDS.BO's P/E ratio is -11.87. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to TCNSBRANDS.BO's ROE of -0.63%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to TCNSBRANDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check TCNSBRANDS.BO's competition here
IRISDOREME.NS vs TCNSBRANDS.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, TCNSBRANDS.NS has a market cap of 36.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while TCNSBRANDS.NS trades at ₹583.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas TCNSBRANDS.NS's P/E ratio is -11.85. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to TCNSBRANDS.NS's ROE of -0.63%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to TCNSBRANDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check TCNSBRANDS.NS's competition here
IRISDOREME.NS vs RAYMOND.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RAYMOND.BO has a market cap of 33.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RAYMOND.BO trades at ₹520.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RAYMOND.BO's P/E ratio is 64.03. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RAYMOND.BO's ROE of +1.53%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RAYMOND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RAYMOND.BO's competition here
IRISDOREME.NS vs RAYMOND.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RAYMOND.NS has a market cap of 33.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RAYMOND.NS trades at ₹520.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RAYMOND.NS's P/E ratio is 98.93. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RAYMOND.NS's ROE of +1.53%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RAYMOND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RAYMOND.NS's competition here
IRISDOREME.NS vs KITEX.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, KITEX.BO has a market cap of 30.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while KITEX.BO trades at ₹157.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas KITEX.BO's P/E ratio is -18.24. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to KITEX.BO's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to KITEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check KITEX.BO's competition here
IRISDOREME.NS vs KITEX.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, KITEX.NS has a market cap of 30.7B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while KITEX.NS trades at ₹157.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas KITEX.NS's P/E ratio is -18.23. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to KITEX.NS's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to KITEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check KITEX.NS's competition here
IRISDOREME.NS vs NITINSPIN.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, NITINSPIN.BO has a market cap of 27.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while NITINSPIN.BO trades at ₹505.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas NITINSPIN.BO's P/E ratio is 16.75. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to NITINSPIN.BO's ROE of +0.13%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to NITINSPIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check NITINSPIN.BO's competition here
IRISDOREME.NS vs NITINSPIN.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, NITINSPIN.NS has a market cap of 27.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while NITINSPIN.NS trades at ₹505.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas NITINSPIN.NS's P/E ratio is 16.72. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to NITINSPIN.NS's ROE of +0.13%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to NITINSPIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check NITINSPIN.NS's competition here
IRISDOREME.NS vs GANECOS.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GANECOS.NS has a market cap of 27.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GANECOS.NS trades at ₹1,030.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GANECOS.NS's P/E ratio is 69.32. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GANECOS.NS's ROE of +0.03%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GANECOS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GANECOS.NS's competition here
IRISDOREME.NS vs GANECOS.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GANECOS.BO has a market cap of 27.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GANECOS.BO trades at ₹1,033.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GANECOS.BO's P/E ratio is 68.86. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GANECOS.BO's ROE of +0.03%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GANECOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GANECOS.BO's competition here
IRISDOREME.NS vs SIYSIL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SIYSIL.BO has a market cap of 27.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SIYSIL.BO trades at ₹611.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SIYSIL.BO's P/E ratio is 13.32. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SIYSIL.BO's ROE of +0.16%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SIYSIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SIYSIL.BO's competition here
IRISDOREME.NS vs SIYSIL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SIYSIL.NS has a market cap of 27.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SIYSIL.NS trades at ₹611.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SIYSIL.NS's P/E ratio is 13.32. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SIYSIL.NS's ROE of +0.16%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SIYSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SIYSIL.NS's competition here
IRISDOREME.NS vs KKCL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, KKCL.NS has a market cap of 27.1B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while KKCL.NS trades at ₹446.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas KKCL.NS's P/E ratio is 19.42. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to KKCL.NS's ROE of +0.16%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to KKCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check KKCL.NS's competition here
IRISDOREME.NS vs KKCL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, KKCL.BO has a market cap of 27.1B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while KKCL.BO trades at ₹445.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas KKCL.BO's P/E ratio is 19.40. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to KKCL.BO's ROE of +0.16%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to KKCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check KKCL.BO's competition here
IRISDOREME.NS vs JINDWORLD.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, JINDWORLD.NS has a market cap of 26.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while JINDWORLD.NS trades at ₹26.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas JINDWORLD.NS's P/E ratio is 40.20. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to JINDWORLD.NS's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to JINDWORLD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check JINDWORLD.NS's competition here
IRISDOREME.NS vs JINDWORLD.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, JINDWORLD.BO has a market cap of 26.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while JINDWORLD.BO trades at ₹26.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas JINDWORLD.BO's P/E ratio is 40.17. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to JINDWORLD.BO's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to JINDWORLD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check JINDWORLD.BO's competition here
IRISDOREME.NS vs MAYURUNIQ.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, MAYURUNIQ.NS has a market cap of 26.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while MAYURUNIQ.NS trades at ₹619.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas MAYURUNIQ.NS's P/E ratio is 15.27. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to MAYURUNIQ.NS's ROE of +0.18%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to MAYURUNIQ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check MAYURUNIQ.NS's competition here
IRISDOREME.NS vs MAYURUNIQ.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, MAYURUNIQ.BO has a market cap of 26.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while MAYURUNIQ.BO trades at ₹618.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas MAYURUNIQ.BO's P/E ratio is 15.22. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to MAYURUNIQ.BO's ROE of +0.18%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to MAYURUNIQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check MAYURUNIQ.BO's competition here
IRISDOREME.NS vs BOMDYEING.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, BOMDYEING.BO has a market cap of 24.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while BOMDYEING.BO trades at ₹120.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas BOMDYEING.BO's P/E ratio is 25.25. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to BOMDYEING.BO's ROE of +0.01%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to BOMDYEING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check BOMDYEING.BO's competition here
IRISDOREME.NS vs BOMDYEING.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, BOMDYEING.NS has a market cap of 24.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while BOMDYEING.NS trades at ₹120.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas BOMDYEING.NS's P/E ratio is 141.55. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to BOMDYEING.NS's ROE of +0.01%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to BOMDYEING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check BOMDYEING.NS's competition here
IRISDOREME.NS vs SANGAMIND.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SANGAMIND.BO has a market cap of 24.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SANGAMIND.BO trades at ₹491.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SANGAMIND.BO's P/E ratio is 29.66. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SANGAMIND.BO's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SANGAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SANGAMIND.BO's competition here
IRISDOREME.NS vs SANGAMIND.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SANGAMIND.NS has a market cap of 23.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SANGAMIND.NS trades at ₹486.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SANGAMIND.NS's P/E ratio is 29.54. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SANGAMIND.NS's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SANGAMIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SANGAMIND.NS's competition here
IRISDOREME.NS vs SPAL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SPAL.NS has a market cap of 19.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SPAL.NS trades at ₹783.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SPAL.NS's P/E ratio is 17.41. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SPAL.NS's ROE of +0.13%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SPAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SPAL.NS's competition here
IRISDOREME.NS vs SPAL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SPAL.BO has a market cap of 19.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SPAL.BO trades at ₹782.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SPAL.BO's P/E ratio is 17.40. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SPAL.BO's ROE of +0.13%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SPAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SPAL.BO's competition here
IRISDOREME.NS vs CANTABIL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, CANTABIL.BO has a market cap of 19B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while CANTABIL.BO trades at ₹221.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas CANTABIL.BO's P/E ratio is 21.35. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to CANTABIL.BO's ROE of +0.23%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to CANTABIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check CANTABIL.BO's competition here
IRISDOREME.NS vs CANTABIL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, CANTABIL.NS has a market cap of 19B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while CANTABIL.NS trades at ₹222.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas CANTABIL.NS's P/E ratio is 21.32. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to CANTABIL.NS's ROE of +0.23%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to CANTABIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check CANTABIL.NS's competition here
IRISDOREME.NS vs SPORTKING.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SPORTKING.BO has a market cap of 18.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SPORTKING.BO trades at ₹140.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SPORTKING.BO's P/E ratio is 15.62. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SPORTKING.BO's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to SPORTKING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SPORTKING.BO's competition here
IRISDOREME.NS vs SPORTKING.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SPORTKING.NS has a market cap of 18.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SPORTKING.NS trades at ₹141.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SPORTKING.NS's P/E ratio is 15.57. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SPORTKING.NS's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to SPORTKING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SPORTKING.NS's competition here
IRISDOREME.NS vs FILATEX.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, FILATEX.BO has a market cap of 18.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while FILATEX.BO trades at ₹42.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas FILATEX.BO's P/E ratio is 9.98. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to FILATEX.BO's ROE of +0.13%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to FILATEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check FILATEX.BO's competition here
IRISDOREME.NS vs FILATEX.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, FILATEX.NS has a market cap of 18.3B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while FILATEX.NS trades at ₹42.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas FILATEX.NS's P/E ratio is 9.96. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to FILATEX.NS's ROE of +0.13%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to FILATEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check FILATEX.NS's competition here
IRISDOREME.NS vs SUMEETINDS.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SUMEETINDS.NS has a market cap of 15.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SUMEETINDS.NS trades at ₹29.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SUMEETINDS.NS's P/E ratio is 0.60. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SUMEETINDS.NS's ROE of +0.90%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SUMEETINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SUMEETINDS.NS's competition here
IRISDOREME.NS vs DOLLAR.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, DOLLAR.NS has a market cap of 14.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while DOLLAR.NS trades at ₹265.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas DOLLAR.NS's P/E ratio is 14.17. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to DOLLAR.NS's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to DOLLAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check DOLLAR.NS's competition here
IRISDOREME.NS vs DOLLAR.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, DOLLAR.BO has a market cap of 14.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while DOLLAR.BO trades at ₹265.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas DOLLAR.BO's P/E ratio is 14.03. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to DOLLAR.BO's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to DOLLAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check DOLLAR.BO's competition here
IRISDOREME.NS vs AYMSYNTEX.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, AYMSYNTEX.BO has a market cap of 13.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while AYMSYNTEX.BO trades at ₹226.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas AYMSYNTEX.BO's P/E ratio is -874.81. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to AYMSYNTEX.BO's ROE of -0.00%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to AYMSYNTEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check AYMSYNTEX.BO's competition here
IRISDOREME.NS vs AYMSYNTEX.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, AYMSYNTEX.NS has a market cap of 13.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while AYMSYNTEX.NS trades at ₹227.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas AYMSYNTEX.NS's P/E ratio is -860.78. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to AYMSYNTEX.NS's ROE of -0.00%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to AYMSYNTEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check AYMSYNTEX.NS's competition here
IRISDOREME.NS vs MONTECARLO.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, MONTECARLO.NS has a market cap of 11.7B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while MONTECARLO.NS trades at ₹583.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas MONTECARLO.NS's P/E ratio is 12.13. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to MONTECARLO.NS's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to MONTECARLO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check MONTECARLO.NS's competition here
IRISDOREME.NS vs MONTECARLO.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, MONTECARLO.BO has a market cap of 11.7B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while MONTECARLO.BO trades at ₹583.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas MONTECARLO.BO's P/E ratio is 12.07. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to MONTECARLO.BO's ROE of +0.12%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to MONTECARLO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check MONTECARLO.BO's competition here
IRISDOREME.NS vs RAJRILTD.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RAJRILTD.NS has a market cap of 11.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RAJRILTD.NS trades at ₹20.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RAJRILTD.NS's P/E ratio is 48.62. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RAJRILTD.NS's ROE of +0.25%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RAJRILTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RAJRILTD.NS's competition here
IRISDOREME.NS vs RUPA.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RUPA.NS has a market cap of 11.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RUPA.NS trades at ₹146.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RUPA.NS's P/E ratio is 16.81. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RUPA.NS's ROE of +0.07%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to RUPA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RUPA.NS's competition here
IRISDOREME.NS vs RUPA.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RUPA.BO has a market cap of 11.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RUPA.BO trades at ₹145.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RUPA.BO's P/E ratio is 16.82. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RUPA.BO's ROE of +0.07%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RUPA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RUPA.BO's competition here
IRISDOREME.NS vs FAZE3Q.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, FAZE3Q.BO has a market cap of 10.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while FAZE3Q.BO trades at ₹459.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas FAZE3Q.BO's P/E ratio is 33.93. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to FAZE3Q.BO's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to FAZE3Q.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check FAZE3Q.BO's competition here
IRISDOREME.NS vs FAZE3Q.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, FAZE3Q.NS has a market cap of 10.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while FAZE3Q.NS trades at ₹455.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas FAZE3Q.NS's P/E ratio is 33.64. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to FAZE3Q.NS's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to FAZE3Q.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check FAZE3Q.NS's competition here
IRISDOREME.NS vs CENTENKA.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, CENTENKA.NS has a market cap of 9.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while CENTENKA.NS trades at ₹444.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas CENTENKA.NS's P/E ratio is 13.90. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to CENTENKA.NS's ROE of +0.05%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to CENTENKA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check CENTENKA.NS's competition here
IRISDOREME.NS vs HIMATSEIDE.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, HIMATSEIDE.BO has a market cap of 9.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while HIMATSEIDE.BO trades at ₹76.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas HIMATSEIDE.BO's P/E ratio is 11.13. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to HIMATSEIDE.BO's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to HIMATSEIDE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check HIMATSEIDE.BO's competition here
IRISDOREME.NS vs HIMATSEIDE.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, HIMATSEIDE.NS has a market cap of 9.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while HIMATSEIDE.NS trades at ₹76.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas HIMATSEIDE.NS's P/E ratio is 11.47. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to HIMATSEIDE.NS's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to HIMATSEIDE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check HIMATSEIDE.NS's competition here
IRISDOREME.NS vs CENTENKA.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, CENTENKA.BO has a market cap of 9.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while CENTENKA.BO trades at ₹444.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas CENTENKA.BO's P/E ratio is 16.10. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to CENTENKA.BO's ROE of +0.05%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to CENTENKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check CENTENKA.BO's competition here
IRISDOREME.NS vs INDORAMA.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, INDORAMA.BO has a market cap of 9.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while INDORAMA.BO trades at ₹35.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas INDORAMA.BO's P/E ratio is 6.72. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to INDORAMA.BO's ROE of +0.37%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to INDORAMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check INDORAMA.BO's competition here
IRISDOREME.NS vs INDORAMA.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, INDORAMA.NS has a market cap of 9.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while INDORAMA.NS trades at ₹35.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas INDORAMA.NS's P/E ratio is 6.70. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to INDORAMA.NS's ROE of +0.37%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to INDORAMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check INDORAMA.NS's competition here
IRISDOREME.NS vs NAHARSPING.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, NAHARSPING.NS has a market cap of 9.1B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while NAHARSPING.NS trades at ₹257.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas NAHARSPING.NS's P/E ratio is 46.68. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to NAHARSPING.NS's ROE of +0.01%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to NAHARSPING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check NAHARSPING.NS's competition here
IRISDOREME.NS vs NAHARSPING.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, NAHARSPING.BO has a market cap of 9.1B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while NAHARSPING.BO trades at ₹256.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas NAHARSPING.BO's P/E ratio is 27.30. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to NAHARSPING.BO's ROE of +0.01%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to NAHARSPING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check NAHARSPING.BO's competition here
IRISDOREME.NS vs AMBIKCO.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, AMBIKCO.BO has a market cap of 8.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while AMBIKCO.BO trades at ₹1,526.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas AMBIKCO.BO's P/E ratio is 14.06. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to AMBIKCO.BO's ROE of +0.07%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to AMBIKCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check AMBIKCO.BO's competition here
IRISDOREME.NS vs AMBIKCO.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, AMBIKCO.NS has a market cap of 8.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while AMBIKCO.NS trades at ₹1,530.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas AMBIKCO.NS's P/E ratio is 13.94. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to AMBIKCO.NS's ROE of +0.07%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to AMBIKCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check AMBIKCO.NS's competition here
IRISDOREME.NS vs GHCLTEXTIL.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GHCLTEXTIL.NS has a market cap of 8.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GHCLTEXTIL.NS trades at ₹86.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GHCLTEXTIL.NS's P/E ratio is 14.40. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GHCLTEXTIL.NS's ROE of +0.05%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GHCLTEXTIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GHCLTEXTIL.NS's competition here
IRISDOREME.NS vs GHCLTEXTIL.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, GHCLTEXTIL.BO has a market cap of 8.2B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while GHCLTEXTIL.BO trades at ₹86.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas GHCLTEXTIL.BO's P/E ratio is 14.35. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to GHCLTEXTIL.BO's ROE of +0.05%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to GHCLTEXTIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check GHCLTEXTIL.BO's competition here
IRISDOREME.NS vs SARLAPOLY.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SARLAPOLY.BO has a market cap of 7.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SARLAPOLY.BO trades at ₹95.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SARLAPOLY.BO's P/E ratio is 11.44. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SARLAPOLY.BO's ROE of -0.03%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SARLAPOLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SARLAPOLY.BO's competition here
IRISDOREME.NS vs SARLAPOLY.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SARLAPOLY.NS has a market cap of 7.8B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SARLAPOLY.NS trades at ₹95.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SARLAPOLY.NS's P/E ratio is -59.15. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SARLAPOLY.NS's ROE of -0.03%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SARLAPOLY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SARLAPOLY.NS's competition here
IRISDOREME.NS vs PRECOT.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, PRECOT.NS has a market cap of 7.6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while PRECOT.NS trades at ₹650.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas PRECOT.NS's P/E ratio is 18.74. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to PRECOT.NS's ROE of +0.06%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to PRECOT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check PRECOT.NS's competition here
IRISDOREME.NS vs RUBYMILLS.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RUBYMILLS.NS has a market cap of 7.5B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RUBYMILLS.NS trades at ₹228.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RUBYMILLS.NS's P/E ratio is 15.54. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RUBYMILLS.NS's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RUBYMILLS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RUBYMILLS.NS's competition here
IRISDOREME.NS vs RUBYMILLS.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RUBYMILLS.BO has a market cap of 7.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RUBYMILLS.BO trades at ₹223.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RUBYMILLS.BO's P/E ratio is 13.84. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RUBYMILLS.BO's ROE of +0.08%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RUBYMILLS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RUBYMILLS.BO's competition here
IRISDOREME.NS vs RSWM.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RSWM.NS has a market cap of 7.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RSWM.NS trades at ₹157.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RSWM.NS's P/E ratio is 37.87. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RSWM.NS's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RSWM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RSWM.NS's competition here
IRISDOREME.NS vs RSWM.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, RSWM.BO has a market cap of 7.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while RSWM.BO trades at ₹156.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas RSWM.BO's P/E ratio is 92.53. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to RSWM.BO's ROE of +0.04%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to RSWM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check RSWM.BO's competition here
IRISDOREME.NS vs UNITEDPOLY.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, UNITEDPOLY.NS has a market cap of 7.4B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while UNITEDPOLY.NS trades at ₹34.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas UNITEDPOLY.NS's P/E ratio is -7.22. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to UNITEDPOLY.NS's ROE of +0.22%. Regarding short-term risk, IRISDOREME.NS is less volatile compared to UNITEDPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for IRISDOREME.NS.Check UNITEDPOLY.NS's competition here
IRISDOREME.NS vs CHEVIOT.NS Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, CHEVIOT.NS has a market cap of 6.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while CHEVIOT.NS trades at ₹1,190.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas CHEVIOT.NS's P/E ratio is 9.86. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to CHEVIOT.NS's ROE of +0.11%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to CHEVIOT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check CHEVIOT.NS's competition here
IRISDOREME.NS vs CHEVIOT.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, CHEVIOT.BO has a market cap of 6.9B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while CHEVIOT.BO trades at ₹1,189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas CHEVIOT.BO's P/E ratio is 9.83. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to CHEVIOT.BO's ROE of +0.11%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to CHEVIOT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check CHEVIOT.BO's competition here
IRISDOREME.NS vs SUTLEJTEX.BO Comparison May 2026
IRISDOREME.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRISDOREME.NS stands at 6.1B. In comparison, SUTLEJTEX.BO has a market cap of 6B. Regarding current trading prices, IRISDOREME.NS is priced at ₹36.59, while SUTLEJTEX.BO trades at ₹36.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRISDOREME.NS currently has a P/E ratio of 46.74, whereas SUTLEJTEX.BO's P/E ratio is -6.70. In terms of profitability, IRISDOREME.NS's ROE is +0.15%, compared to SUTLEJTEX.BO's ROE of -0.10%. Regarding short-term risk, IRISDOREME.NS is more volatile compared to SUTLEJTEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for IRISDOREME.NS.Check SUTLEJTEX.BO's competition here